Therapeutic testing of the clinical candidate drug PMX205 in a TDP43-based model of MND and its mechanism (2018–2019)

Grant type:
Motor Neurone Disease Research Institute of Australia Inc
Researchers:
Funded by:
Motor Neurone Disease Research Institute of Australia Inc